BROSSARD, Quebec, March 31, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early …
BROSSARD, Quebec, Feb. 28, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in early de…
In the original press release dated February 5, 2025, announcing the closing of a private placement of 6,715,370 units issued at a price of $0.30 per unit, for gros…
BROSSARD, Quebec, Feb. 05, 2025 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection o…
BROSSARD, Quebec, Nov. 12, 2024 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) a pioneer in early de…
The TSX Venture Exchange has released its yearly list of the 50 best-performing companies for 2024, and tech companies out west made a particularly strong showing.
/PRNewswire/ - Diagnos (TSXV: ADK) (OTCQB: DGNOF) (FRA: 4D4A) is opening clinics and forming distribution partnerships all over the world, including Canada,...